Your Shopping Cart
No Items
Written by: Amy Baxter | Senior Housing News
With strong tailwinds buoyed by promising demographics, the U.S. senior housing industry has become very attractive not only to the traditional buyers of health care real estate, but also increasingly to private equity and overseas investors.
As health care real estate investment trusts continue to make strategic dispositions and refocus their portfolios, foreign capital is seizing acquisition and joint venture opportunities with some of the biggest senior living real estate holders, according to a report released this week from credit-rating company Fitch Ratings.
“Foreign investors are increasingly looking to invest in US healthcare real estate, particularly those with longer term horizons such as sovereign wealth funds, pension funds and insurance companies,” Fitch writes.
Buyers and Sellers in 2016
After record transactions recorded in 2015, REITs took a step back in their acquisition activity in 2016, instead becoming net sellers. Picking up the slack in M&A was private equity, according to Fitch.
The “Big 3” health care REITs—HCP Inc. (NYSE: HCP), Ventas Inc. (NYSE: VTR) and Welltower Inc. (NYSE: HCN)—have all announced major sales this year involving private equity groups, in some form, or sales with foreign buyers.
“The increasing role of private equity and foreign capital has been as much about them as it has been REITs selling,” Britton Costa, an analyst with Fitch Ratings, told Senior Housing News. “The largest REITs have been selling to reduce leverage and because equity via asset sales was cheaper than issuing new shares. We believe they have leverage where they’d like it so they have less motivation to pare their portfolios to the same extent.”
University of Miami Life Science & Technology Park, a property under a US healthcare REIT. (Photo: Ventas REIT)
Posted on 11/21/2016 at 12:46 PM
All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.
